Exelixis Overview

Exelixis, Inc. (Nasdaq: EXEL) is a leading genomics-based drug discovery company focused on the discovery and development of innovative new drugs for cancer and other major human diseases. Through its integrated biological platform and expertise in comparative genomics and model system genetics, Exelixis is able to find novel, proprietary drug targets that would be difficult or impossible to...More»

Exelixis, Inc. (Nasdaq: EXEL) is a leading genomics-based drug discovery company focused on the discovery and development of innovative new drugs for cancer and other major human diseases. Through its integrated biological platform and expertise in comparative genomics and model system genetics, Exelixis is able to find novel, proprietary drug targets that would be difficult or impossible to uncover using other approaches. Internally, Exelixis has built an aggressive high-throughput screening and chemistry facility in order to accelerate these targets through the drug discovery process. Exelixis' partners use these targets as the basis for new drugs for a variety of diseases.«Less